Pharmacogenetic challenges in the treatment of mental diseases
Sukhanov, V.A.; Piruzian, L.A.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(8): 83-86
2004
ISSN/ISBN: 1997-7298 PMID: 15554149 Document Number: 583013
Document emailed within 1 workday
Related Documents
Shimoda, K. 2009: Progress on pharmacogenetic study in psychiatry and future prospects of order-made drug therapy for mental disorders Seishin Shinkeigaku Zasshi 111(12): 1546-1551Löhr, G.W.; Blume, K.G.; Arnold, H. 1973: Pharmacogenetic causes in manifestation of hematologic diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 235-245
Kaaya, S.; Eustache, E.; Lapidos-Salaiz, I.; Musisi, S.; Psaros, C.; Wissow, L. 2013: Grand challenges: Improving HIV treatment outcomes by integrating interventions for co-morbid mental illness Plos Medicine 10(5): E1001447
Molyneux, D.H. 2023: Mental health and neglected tropical diseases - the neglected dimension of burden: identifying the challenges and understanding the burden International Health 15(Suppl_3): Iii3-Iii6
Schmiegelow, K.; Hertz, H. 1998: Thiopurine treatment. Significance of pharmacogenetic polymorphism Ugeskrift for Laeger 160(8): 1189-1191
Sternalski, M. 1970: Use of Lyogen in the treatment of mental diseases in children Przeglad Lekarski 26(3): 403-404
Budzinskaia, M.V.; Pogoda, T.V.; Generozov, E.V.; Chikun, E.A.; Gurova, I.V.; Shchegoleva, I.V.; Sizova, M.V. 2013: Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration Vestnik Oftalmologii 129(5): 128-135
Deng, Y.; Gaebel, J.; Denecke, K. 2016: Patient Centered Event Representation for the Treatment of Multifactorial Diseases: Current Progress and Challenges Studies in Health Technology and Informatics 228: 110-114
Balabolkin, I.I.; Bulgakova, V.A. 2016: Pharmacogenetic Markers of the Effectiveness of Treatment of Children with Atopic Bronchial Asthma Eksperimental'naia i Klinicheskaia Farmakologiia 79(11): 35-40
Dencker, S.J. 1979: Treatment with high doses of neuroleptics in the acute phase of mental diseases Acta Psiquiatrica y Psicologica de America Latina 25(2): 157-160
Smulevich, A.B.; Syrkin, A.L.; Drobizhev, M.I.; Drozdov, D.V. 1994: Alprazolam and bromazepam in the treatment of the mental disorders in patients with cardiovascular diseases Terapevticheskii Arkhiv 66(12): 26-30
Iablochkina, I.S. 1970: Work therapy and rehabilitation of patients with long term mental diseases in the Tomsk mental hospital Meditsinskaia Sestra 29(3): 48
Draganov, P. 1970: Role, significance and organization of working and recreational therapies in rehabilitation treatment of chronic mental diseases Neuropsihijatrija 18(4): 313-316
Rutz, W. 2001: Mental health in Europe: problems, advances and challenges Acta Psychiatrica Scandinavica. Supplementum 2001(410): 15-20
Holmwood, C. 1998: Challenges facing primary care mental health in Australia Australian Family Physician 27(8): 716-719
Hese, R.T.; Kret, K. 1980: Opinions of the patients of the psychiatric department, medical students and students of psychology on mental diseases and preservation of mental health Psychiatria Polska 14(4): 383-388
Klapchuk, V.V. 1986: Changes in the physiologic indices of mental and physical work capacity among workers with lung diseases engaged in mental work and participating in various exercise programs Fiziologiia Cheloveka 12(2): 249-252
Jegannathan, B.; Kullgren, G.; Deva, P. 2015: Mental health services in Cambodia, challenges and opportunities in a post-conflict setting Asian Journal of Psychiatry 13: 75-80
Pinto-Foltz, M.D.; Logsdon, M.C.; Derrick, A. 2011: Engaging adolescent mothers in a longitudinal mental health intervention study: challenges and lessons learned Issues in Mental Health Nursing 32(4): 214-219
Mellins, C.A.; Malee, K.M. 2013: Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges Journal of the International Aids Society 16: 18593